Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 20 Source: CRO
- €4.1 billion turnover
-
-€121.6 million
profit - 11,500 employees
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
- 6 more years available »
Ranking
By Turnover
(€4.1 billion)- 30th in Top Companies
- 8th in Health
- 5th in Pharma
By Employees
(11,500)- 19th in Top Companies
- 4th in Health
- 3rd in Pharma
-
- 11,500
- €4.1 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- 11:58am Grant Thornton was forensic auditor on Greensill-GAM probe
- 11:03am Ardagh confirms it was hit by cyber attack
- 10:51am Heineken weighs takeover of South Africa’s Distell Group
- 10:43am European stocks head towards all-time highs as Fed fears abate
- 8:29am Vodafone misses market expectations with 1.2% drop in earnings